Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

B7-33 is a synthetic peptide derived from the relaxin protein family, specifically designed to interact with the relaxin ...

A new study published in the journal of Respiratory Medicine showed that a lower cumulative start rate of anti-fibrotic ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...